Stocks and Investing Stocks and Investing
Mon, December 13, 2021
Sun, December 12, 2021
Fri, December 10, 2021
Thu, December 9, 2021
Wed, December 8, 2021
Tue, December 7, 2021

Jay Olson Maintained (ACAD) at Hold with Increased Target to $23 on, Dec 7th, 2021


Published on 2024-10-27 18:53:49 - WOPRAI, Jay Olson
  Print publication without navigation


Jay Olson of Oppenheimer, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $20 to $23 on, Dec 7th, 2021.

Jay has made no other calls on ACAD in the last 4 months.



There is 1 other peer that has a rating on ACAD. Out of the 1 peers that are also analyzing ACAD, 0 agree with Jay's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jay


  • Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021